Showing results (81-90 of 251) with videos related to
Sort By:
Pageof 26
Peerj|November 4, 2024
A comparative study on the lipid layer thickness analysis of medical staff before and after workQian Li, Xiufen Liu, Yu Ren, et al.Frontiers in Immunology|January 31, 2022
Communication Pattern Changes Along With Declined IGF1 of Immune Cells in COVID-19 Patients During Disease ProgressionMin Zhao, Zhen Liu, Fei Shao, et al.Bioresource Technology|August 23, 2014
Activated sludge filterability improvement by nitrifying bacteria abundance regulation in an adsorption membrane bioreactor (Ad-MBR)Fei-Yun Sun, Xiao-Mei Lv, Ji Li, et al.Scientific Reports|October 7, 2024
Interfacial energy conversion mechanism between 3003 aluminum alloy and 321 stainless steel in vaporizing foil actuator welding processShan Su, Wei Duan, Yuanyuan Wu, et al.Cancer Immunology, Immunotherapy : CII|December 31, 2024
Integrated multi-omics analysis reveals clinical significance of hepatocyte nuclear factor-1β in tumor immune microenvironment, immunotherapy and prognostic prediction for colon adenocarcinomaFushan Gao, Wenlin Gong, Haihua He, et al.Molecules (Basel, Switzerland)|May 25, 2024
Research Progress of Natural Active Substances with Immunosuppressive ActivityFei Shao, Qiying Shen, Zhengfei Yang, et al.Nature Communications|June 5, 2024
Microbiota regulates the TET1-mediated DNA hydroxymethylation program in innate lymphoid cell differentiationXusheng Zhang, Xintong Gao, Zhen Liu, et al.Journal of Experimental & Clinical Cancer Research : CR|June 25, 2017
High expression of Collagen Triple Helix Repeat Containing 1 (CTHRC1) facilitates progression of oesophageal squamous cell carcinoma through MAPK/MEK/ERK/FRA-1 activationChunni Wang, Zitong Li, Fei Shao, et al.Frontiers in Oncology|February 6, 2023
Identification of IRF-associated molecular subtypes in clear cell renal cell carcinoma to characterize immunological characteristics and guide therapyCan Chen, Lin-Yuan Chen, Rui-Xia Yang, et al.Asian Pacific Journal of Cancer Prevention : APJCP|April 30, 2013
AntagomiR-27a targets FOXO3a in glioblastoma and suppresses U87 cell growth in vitro and in vivoYun-Fei Ge, Jun Sun, Chun-Jie Jin, et al.Pageof 26